PublizoomAward notice Supplies
7ª Prórroga + MODIFICACION Suministro de RAVULIZUMAB (ULTOMIRIS) solución inyectable, de distribución exclusiva para el Servicio de Farmacia del Hospital Clínico San Carlos de Madrid.
Notice published in Spanish. The AI analysis summarises it for you in your language.
- Public buyer
- HOSPITAL CLINICO SAN CARLOS DE MADRID
MADRID - Place of performance
- Madrid
- Estimated value
- €8,765,039 excl. VAT
- Amount awarded
- €2,022,701 excl. VAT
- Bids received
- 1
- Procedure
- Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part. - Publication
- 5 October 2026
- Notice language
- Spanish
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
7ª Prórroga + MODIFICACION Suministro de RAVULIZUMAB (ULTOMIRIS) solución inyectable, de distribución exclusiva para el Servicio de Farmacia del Hospital Clínico San Carlos de Madrid.
Awarded to
2 lots
- RAVULULIZUMAB 1.100MG/11 ML VIAL
- RAVULIZUMAB 300MG/3 ML VIAL
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €350,000
- Median
- €846,164
- A quarter above
- €2,267,877
Amounts awarded (excl. VAT) over the last 3 years for 265 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 685056-2026.